Frequency of Viral Replication Markers in Chronic HBV Carriers in N’Djamena, Chad
- 1 Service de Médecine Interne et Gastroentérologie, CHU La Référence Nationale de N’Djamena, N’Djamena, Tchad
- 2 Service de Médecine Interne et Gastroentérologie, CHU La Référence Nationale de N’Djamena, N’Djamena, Tchad
- 3 Département des Sciences Biomédicales et Pharmaceutiques, Faculté des Sciences de la Santé Humaine, Université de N’Djamena, N’Djamena, Tchad
- 4 Service de Médecine Interne et Gastroentérologie, CHU La Référence Nationale de N’Djamena, N’Djamena, Tchad
- 5 Programme National de Lutte Contre le VIH/IST/Hépatite, Ministère de la Santé Publique, N’Djamena, Tchad
- 6 Département des Sciences Biomédicales et Pharmaceutiques, Faculté des Sciences de la Santé Humaine, Université de N’Djamena, N’Djamena, Tchad
Abstract
Introduction: According to the WHO, Chad is located in an area of high endemicity for hepatitis B virus (HBV). The aim of this study was to analyze the virological profiles of chronic HBV carriers. Materials and Method: This was a retrospective and analytical study including outpatients with chronic HBV of any age received in Department of Internal Medicine and Gastroenterology of National General Reference Hospital of N’Djamena from 2013 to 2017. Results: During the study period, 401 chronic hepatitis B virus carriers (mean age was 35 years ± 11 years with sex ratio of 3.26) were seen in outpatient clinic with a frequency of 3.34% (401/11,988). HBeAg (+) patients were 12.8% and HBeAg negative 87.2%. HBeAg-negative patients were significantly older (p = 0.000) than those with HBeAg (+). The mean HBV-DNA level was higher in HBeAg (+) patients. The HBV-DNA level in HBeAg-positive patients was higher than in HBeAg-negative patients with a significant difference (p = 0.043). The mean ALT level was 45 IU/L in HBeAg ( − ) patients. It was 49 in HBeAg (+) patients. Conclusion: HBeAg ( − ) chronic hepatitis B is the most predominant form in our study. This observation is important because it can help to adapt the management strategies.
- World Health Organization (2021) Global Progress Report on HIV, Viral Hepatitis and Sexually Transmitted Infections. World Health Organization, Geneva.
- Ganem, D. and Prince, A.M. (2004) Mecanism of Disease: Hepatitis B Virus Infection-Natural History and Clinical Consequences. The New England Journal of Medicine, 350, 1118-1129. https://doi.org/10.1056/NEJMra031087
- Ganem, D. and Prince, A.M. (2004) Mecanism of Disease: Hepatitis B Virus Infection—Natural History and Clinical Consequences. New England Journal of Medicine, 350, 1118-1129. https://doi.org/10.1056/NEJMra031087
- Aubry, P. and Gauzère, B. (2022) Hépatites virales en zone tropicale Actualités 2022. http://medecinetropicale.free.fr/cours/hepatite_virale.pdf
- European Association for the Study of Liver (2017) EASL 2017 Clinical Practice Guidelines on the Management of Hepatitis B Virus Infection. Journal of Hepatology, 67, 370-398. https://doi.org/10.1016/j.jhep.2017.03.021
- Gkouvatos, K., Goussens, N., Spahr, L. and Negro, F. (2017) Hépatite B: Nouvelles recommandations de prise en charge. Revue Médicale Suisse, 3, 1458-1463. https://doi.org/10.53738/REVMED.2017.13.572.1458
- Maclachlan, J.H. and Benjamin, C. (2015) Hepatitis B Virus Epidemiology. Cold Spring Harbor Perspectives in Medicine, 5, Article ID: a021568. https://doi.org/10.1101/cshperspect.a021568
- Amadu, N., Alhassan, A., Obirikorang, C., Feglo, P., Majeed, S.F., Timmy-Doukoh, E.E., Afful, D., et al. (2015) Sero-Prevalence of Hepatitis B Surface Antigen in Three Densely Populated Communities in Kumasi, Ghana. Journal of Medical and Biomedical Sciences, 1, 59-65.
- Diallo, S., Bassane, M.L., Gueye, M.N., Thioubou, M., Dia, D., Mbengue, M., Diouf M., et al. (2018) Hépatite Virale B: Aspect clinique, para clinique et évolutif au service d’hépato gastroentérologie de l’Hôpital Aristide le Dantec. The Pan African Médical Journal, 31, Article No. 82. https://doi.org/10.11604/pamj.2018.31.82.14725
- Institut de veille Sanitaire de France. Rapport d’enquête de prévalence de l’hépatite B et C. Décembre 2006. https://www.vie-publique.fr/
- Agbenu, E., Banla, M., Almeida, A., Kpostsra, A., Dorkonoo, A. and Redah, D. (2008) Marqueurs sérologiques utilisés dans la surveillance de l’infection par le virus de l’hépatite B au Togo: Etat des lieux et propositions. Médecine Tropicale, 68, 621-624.
- Ankouane, F., Kowo, M., Njoya, O., Biwolé Sida, M., Tzeuton, C. and Ndjitoyap, N.E.C. (2015) Hépatite B chronique à AgHBe négatif à Yaoundé, Cameroun. Health Sciences and Disease, 16, 1-5.